Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion type Assertion NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_head.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion description "[Silencing BAG3 reduced Mcl-1 protein levels and overcame ABT-737 resistance in several of the cell lines, including triple-negative breast cancer (MDA-MB231) and androgen receptor-negative prostate cancer (PC3) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion evidence source_evidence_literature NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion SIO_000772 23341456 NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion wasDerivedFrom befree-20140225 NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.
- NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_assertion wasGeneratedBy ECO_0000203 NP410459.RAxqQ1ow1soXPwj3jCy2uKVuVYncx91AORzbnMxU_WT6E130_provenance.